Keywords
Last Name
Institution

Upendra P Hegde MD

TitleAssociate Professor
InstitutionUConn Health Center
DepartmentMedicine
AddressMC 1628
MC 1628
263 Farmington Avenue
Phone860-679-2257
Fax860-679-4451
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionUConn Health Center
    DepartmentNeag Cancer Center

    TitleCo-director
    InstitutionUConn Health Center
    DepartmentNeag Cancer Center
    DivisionHead and Neck Cancer/Oral Oncology Program


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Lalla RV, Choquette LE, Curley KF, Dowsett RJ, Feinn RS, Hegde UP, Pilbeam CC, Salner AL, Sonis ST, Peterson DE. Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer. Oral Oncol. 2014 Nov; 50(11):1098-103. PMID: 25151488.
      View in: PubMed
    2. Hegde UP, Grant-Kels JM. Metastatic melanoma in the older patient: special considerations. Clin Dermatol. 2013 May-Jun; 31(3):311-6. PMID: 23608450.
      View in: PubMed
    3. Chakraborty NG, Yadav M, Dadras SS, Singh P, Chhabra A, Feinn R, Kerr PE, Grant-Kels JM, Mukherji B, Hegde UP. Analyses of T cell-mediated immune response to a human melanoma-associated antigen by the young and the elderly. Hum Immunol. 2013 May; 74(5):640-7. PMID: 23391568.
      View in: PubMed
    4. Hegde UP, Grant-Kels JM. Ethical issues in cutaneous melanoma. Clin Dermatol. 2012 Sep-Oct; 30(5):501-10. PMID: 22902221.
      View in: PubMed
    5. Ahmed N, Usmani S, Jabbour N, Hegde U. Acute psychosis after paclitaxel infusion. Conn Med. 2011 Sep; 75(8):465-6. PMID: 21980675.
      View in: PubMed
    6. Hegde UP, Chakraborty N, Mukherji B, Grant Kels JM. Metastatic melanoma in the older patient: immunologic insights and treatment outcomes. Expert Rev Pharmacoecon Outcomes Res. 2011 Apr; 11(2):185-93. PMID: 21476820.
      View in: PubMed
    7. Trikudanathan G, Philip A, Hegde UP. Intrathoracic lymphadenopathy: sarcoidosis or metastatic seminoma? The diagnostic dilemma revisited. Conn Med. 2010 Aug; 74(7):403-6. PMID: 20806619.
      View in: PubMed
    8. Ray S, Chhabra A, Chakraborty NG, Hegde U, Dorsky DI, Chodon T, von Euw E, Comin-Anduix B, Koya RC, Ribas A, Economou JS, Rosenberg SA, Mukherji B. MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro. Clin Immunol. 2010 Sep; 136(3):338-47. PMID: 20547105; PMCID: PMC2917536.
    9. Hegde UP, Chakraborty N, Kerr P, Grant-Kels JM. Melanoma in the elderly patient: relevance of the aging immune system. Clin Dermatol. 2009 Nov-Dec; 27(6):537-44. PMID: 19880041.
      View in: PubMed
    10. Wilson WH, Dunleavy K, Pittaluga S, Hegde U, Grant N, Steinberg SM, Raffeld M, Gutierrez M, Chabner BA, Staudt L, Jaffe ES, Janik JE. Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers. J Clin Oncol. 2008 Jun 1; 26(16):2717-24. PMID: 18378569; PMCID: PMC2409217.
    11. Hegde U, Chhabra A, Chattopadhyay S, Das R, Ray S, Chakraborty NG. Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes. Pathobiology. 2008; 75(3):200-8. PMID: 18550918.
      View in: PubMed
    12. Mehrotra S, Chhabra A, Hegde U, Chakraborty NG, Mukherji B. Inhibition of c-Jun N-terminal kinase rescues influenza epitope-specific human cytolytic T lymphocytes from activation-induced cell death. J Leukoc Biol. 2007 Feb; 81(2):539-47. PMID: 17062604.
      View in: PubMed
    13. Silverman DI, Cirullo L, DeMartinis NA, Damato K, DeMeo M, Fernandez GA, Glynn L, Hegde U, Laskay E, Leger R, Abu-Hasaballah K, Caron JM. Systematic identification and classification of adverse events in human research. Contemp Clin Trials. 2006 Jun; 27(3):295-303. PMID: 16624631.
      View in: PubMed
    14. Chattopadhyay S, Mehrotra S, Chhabra A, Hegde U, Mukherji B, Chakraborty NG. Effect of CD4+CD25+ and CD4+CD25- T regulatory cells on the generation of cytolytic T cell response to a self but human tumor-associated epitope in vitro. J Immunol. 2006 Jan 15; 176(2):984-90. PMID: 16393984.
      View in: PubMed
    15. Sudheendra D, Barth MM, Hegde U, Wilson WH, Wood BJ. Radiofrequency ablation of lymphoma. Blood. 2006 Feb 15; 107(4):1624-6. PMID: 16254135; PMCID: PMC1895403.
    16. Li Z, Qiao Y, Liu B, Laska EJ, Chakravarthi P, Kulko JM, Bona RD, Fang M, Hegde U, Moyo V, Tannenbaum SH, Ménoret A, Gaffney J, Glynn L, Runowicz CD, Srivastava PK. Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia. Clin Cancer Res. 2005 Jun 15; 11(12):4460-8. PMID: 15958631.
      View in: PubMed
    17. Hegde U, Filie A, Little RF, Janik JE, Grant N, Steinberg SM, Dunleavy K, Jaffe ES, Abati A, Stetler-Stevenson M, Wilson WH. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood. 2005 Jan 15; 105(2):496-502. PMID: 15358629.
      View in: PubMed
    18. Leonard GD, Hegde U, Butman J, Jaffe ES, Wilson WH. Extraoular muscle palsies in subcutaneous panniculitis-like T-cell lymphoma. J Clin Oncol. 2003 Aug 1; 21(15):2993-5. PMID: 12885820.
      View in: PubMed
    19. Hegde UP, Wilson WH, White T, Cheson BD. Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia. Blood. 2002 Sep 15; 100(6):2260-2. PMID: 12200396.
      View in: PubMed
    20. Hegde U, Wilson WH. Gene expression profiling of lymphomas. Curr Oncol Rep. 2001 May; 3(3):243-9. PMID: 11296135.
      View in: PubMed
    21. Handa H, Hegde UP, Kotelnikov VM, Mundle SD, Dong LM, Burke P, Rose S, Hsu WT, Gaskin F, Raza A, Preisler HD. The effects of 13-cis retinoic acid and interferon-alpha in chronic myelogenous leukemia cells in vivo in patients. Leuk Res. 1997 Nov-Dec; 21(11-12):1087-96. PMID: 9444943.
      View in: PubMed
    22. Handa H, Hegde UP, Kotelnikov VM, Mundle SD, Dong LM, Burke P, Rose S, Gaskin F, Raza A, Preisler HD. Bcl-2 and c-myc expression, cell cycle kinetics and apoptosis during the progression of chronic myelogenous leukemia from diagnosis to blastic phase. Leuk Res. 1997 Jun; 21(6):479-89. PMID: 9279359.
      View in: PubMed
    23. Miedema F, Terpstra FG, Smit JW, Daenen S, Gerrits W, Hegde U, Matutes E, Catovsky D, Greaves MF, Melief CJ. Functional properties of neoplastic T cells in adult T cell lymphoma/leukemia patients from the Caribbean. Blood. 1984 Feb; 63(2):477-81. PMID: 6318867.
      View in: PubMed
    Hegde's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _